Peter A. Sillevis Smitt

Erasmus MC — Netherlands

Medicine · Health Sciences

22h-index2.9kcitations108works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(40), Autoimmune Neurological Disorders and Treatments(18), RNA Research and Splicing(15), RNA modifications and cancer(14), Epigenetics and DNA Methylation(13)

Publications87 total

P12.42.A EARLY [18F]FET PET-MRI FOLLOW-UP IN IDH-MUTANT GLIOMA PATIENTS TREATED WITH VORASIDENIB
Neuro-Oncology·2025Open Access
Clinical impact and safety of brain biopsy in unexplained central nervous system disorders: a real‐world cohort study
Annals of Clinical and Translational Neurology·2025· 2 citedOpen Access
Long-Term Cognitive, Functional, and Patient-Reported Outcomes in Patients With Anti-NMDAR Encephalitis
Neurology·2024· 23 citedOpen Access
Autoimmune Encephalitis and Paraneoplastic Neurologic Syndromes
Neurology Neuroimmunology & Neuroinflammation·2024· 21 citedOpen Access
Cognition and health-related quality of life in long-term survivors of high-grade glioma: an interactive perspective from patient and caregiver
Acta Neurochirurgica·2024· 5 citedOpen Access
Table S3 from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen
2024Open Access
Table S2 from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen
2024Open Access
Table S2 from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen
2024Open Access
Table S5 from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen
2024Open Access
Table S3 from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen
2024Open Access
Supplementary Appendix from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen
2024Open Access
Table S6 from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen
2024Open Access
Supp Figures from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen
2024Open Access
Supplemental Figures Legends from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen
2024Open Access
Supp Figures from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen
2024Open Access
Supplemental Figures Legends from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen
2024Open Access
Table S4 from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen
2024Open Access
Data from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen
2024Open Access
Table S1 from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen
2024Open Access
Supplementary Appendix from The Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen
2024Open Access
page 1 of 5Next →

Frequent Co-authors

Martin J. van den Bent(25), Hui Gan(19), Pim J. French(18), Mathilde C.M. Kouwenhoven(16), Kevin C. Johnson(14), Frederick S. Varn(14), Emre Kocakavuk(14), Jill S. Barnholtz‐Sloan(14), Marion Smits(14), Mustafa Khasraw(13), Johanna M. Niers(13), D. Ryan Ormond(13), Laila Poisson(13), Guido Reifenberger(13), Erwin G. Van Meir(13), Michael Weller(13), Bart A. Westerman(13), Lucy F. Stead(13), Theo M. Luider(13), Luciano Garofano(12)